Validation of T classifications in the 7th edition UICC staging system and recommendation of a simplified T classifications based on intensity-modulated radiotherapy
|更新时间:2025-12-31
|
Validation of T classifications in the 7th edition UICC staging system and recommendation of a simplified T classifications based on intensity-modulated radiotherapy
China OncologyVol. 26, Issue 12, Pages: 1012-1017(2016)
黄 爽, 姜 锋, 陈媛媛. Validation of T classifications in the 7th edition UICC staging system and recommendation of a simplified T classifications based on intensity-modulated radiotherapy[J]. China Oncology, 2016, 26(12): 1012-1017.
黄 爽, 姜 锋, 陈媛媛. Validation of T classifications in the 7th edition UICC staging system and recommendation of a simplified T classifications based on intensity-modulated radiotherapy[J]. China Oncology, 2016, 26(12): 1012-1017. DOI: 10.19401/j.cnki.1007-3639.2016.12.008.
Validation of T classifications in the 7th edition UICC staging system and recommendation of a simplified T classifications based on intensity-modulated radiotherapy
背景与目的:调强放射治疗可以明显提高鼻咽癌的局部控制率,使T分期的预后价值发生改变。本文拟评价接受调强放射治疗的鼻咽癌患者国际抗癌联盟(Union for International Cancer Control,UICC)第7版分期中T分期的预后价值,并对其简化方式进行探讨。方法:回顾浙江省肿瘤医院放疗科2007年1月—2011年6月收治的641例初治鼻咽癌患者的基本资料,采用Kaplan-Meier法及COX回归评价UICC第7版分期中T分期的预后价值。结果:641例患者的5年总生存率(overall survival,OS)、无局部复发生存率(loco-relapse free survival,LRFS)、无进展生存率(progression-free survival,PFS)和无远处转移生存率(distant metastasis free survival,DMFS)分别为85.4%、88.5%、78%和87.1%,其中T
Background and purpose: The application of intensity-modulated radiothera
py (IMRT) has improved the local control rate of nasopharyngeal carcinoma greatly
which changed the predictive value of T classifications of TNM staging system. This study aimed to validate the predictive effect of T classifications in the 7th Union for International Cancer Control (UICC) staging system and discuss the simplification of T classifications. Methods: We retrospectively reviewed the clinical data of 641 primary nasopharyngeal carcinoma patients at our center from January 2007 to June 2011. We evaluated the predictive effect of T classifications by Kaplan-Meier method and Cox regression model. Results: The 5-year overall survival (OS)
local relapse-free survival (LRFS)
progression-free survival (PFS) and distant metastasis free survival (DMFS) were 85.4%
88.5%
78% and 87.1%
respectively. The 5-year OS of T
1
T
2
T
3
and T
4
categories were 91.6%
85.3%
90.1% and 76.5%
respectively; LRFS were 93%
85.3%
91.5% and 84.4%; PFS were 88.2%
77.3%
80.8% and 70.9%; DMFS were 95.1%
88.9%
88.2% and 81.3%
respectively. The difference in survival curves between T
1
T
2
and T
3
were not significant (P0.05). However
several prognostic indexes were significantly different between T
4
and T
1
T
2
T
3
. We merged the T
1
T
2
and T
3
classifications as new T
1
and the T
4
classification as new T
2
. The 5-year OS of new T
1
and T
2
were 89.1% and 76.5% (P=0.001); LRFS were 90.1% and 84.4% (P=0.028); PFS were 81% and 70.9% (P=0.001); DMFS were 90.8% and 81.2% (P=0.002). The survival curves were substantially separated. The simplified T classifications had obvious advantages when separately analyzed in different N stages. Conclusion: In the era of IMRT
the predictive effect of T classifications of the 7th UICC staging system has diminished. The simplification of T classifications can fit with the new treatment and
The diagnostic value of zero echo time magnetic resonance imaging for skull base bone invasion in nasopharyngeal carcinoma
A comparative analysis of the long-term efficacy between partial hepatectomy and transcatheter arterial chemoembolization in patients with liver metastasis from nasopharyngeal carcinoma
Study on the mechanism of DDX6 promoting proliferation and migration of nasopharyngeal carcinoma cells by regulating stability of CKMT1A mRNA
Mechanism of circular RNA hsa_circ_0012779 expression in nasopharyngeal carcinoma and its influence on cell biological behavior
Application of generalized equivalent uniform dose optimization in the treatment of nasopharyngeal carcinoma with intensity-modulated radiotherapy
Related Author
Jiahao LIN
Meimei FENG
Kongqi LIN
Fengjie LIN
Yunbin CHEN
Yilin WANG
Lu WANG
Jiayan XIONG
Related Institution
Department of Radiation Oncology, Fujian Cancer Hospital, Clinical Oncology School of Fujian Medical University
Department of Radiology, Fujian Cancer Hospital, Clinical Oncology School of Fujian Medical University
Department of Liver Surgery, Fudan University Shanghai Cancer Center; Department of Oncology, Shanghai Medical College, Fudan University
Research Institute of Otolaryngology Head and Neck Surgery, Affiliated Hospital of Nantong University